Plus, handling vision loss during the holidays.
| | | | | We have the answer! This drug that’s currently in clinical trials may have the ability to repair the myelin sheath—the protective sheath that covers nerves in the brain and spinal cord—in people with multiple sclerosis. If it proves successful, PIPE 307 could offer a novel way to stave off MS progression. |
|
|
| | | | | Percent of the more than 500 respondents to our Chronic at Work Survey who said their condition affects their ability to do their job more than 10 days a month. Another 14% said their symptoms affected them at work four to nine days a month. |
|
|
| #Let’s Get Social | | Deciding whether to reveal your chronic condition(s) to the people you work with is a deeply personal and complex choice, and while there are benefits to being transparent, there are also risks. Head to HealthCentral’s Instagram for advice from physician and public health advocate Alek Patel, M.D., on navigating the complicated question of disclosure. The good news: With each story that gets told, we’re slowly but surely breaking down preconceptions and building a more inclusive world. | | Facebook Pinterest Twitter | | | | |
|
|
|
